Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AMRZ
1951
PUT
Amrize Ltd
AMRZ
$20.4B
| $26.7M | ﹤0.01% |
477,400
+125,700
| +36% | +$7.21M |
2025 Q3
2 quarters
|
|
1952
PUT
SAP
SAP
$241B
| $26.7M | ﹤0.01% |
156,200
+8,500
| +6% | +$1.75M |
2016 Q2
39 quarters
|
|
1953
CALL
MasTec
MTZ
$17.3B
| $26.7M | ﹤0.01% |
83,100
-2,600
| -3% | -$704K |
2013 Q2
51 quarters
|
|
1954
CALL
Revolution Medicines
RVMD
$44.3B
| $26.7M | ﹤0.01% |
274,900
+151,100
| +122% | +$15.3M |
2022 Q3
14 quarters
|
|
|
DEC
1955
Diversified Energy Company
DEC
$926M
| $26.7M | ﹤0.01% |
1,531,035
+271,457
| +22% | +$3.82M |
2024 Q1
8 quarters
|
|
1956
United Bankshares
UBSI
$6.41B
| $26.7M | ﹤0.01% |
644,254
+574,740
| +827% | +$23.9M |
2022 Q3
14 quarters
|
|
1957
Veeva Systems
VEEV
$44.3B
| $26.6M | ﹤0.01% |
151,543
-191,150
| -56% | -$37.6M |
2020 Q2
23 quarters
|
|
1958
Vertiv
VRT
$97.1B
| $26.6M | ﹤0.01% |
106,123
-688,139
| -87% | -$153M |
2020 Q1
24 quarters
|
|
1959
CALL
Pultegroup
PHM
$22B
| $26.6M | ﹤0.01% |
225,900
+92,000
| +69% | +$11.8M |
2013 Q2
51 quarters
|
|
1960
Zeta Global
ZETA
$8.19B
| $26.6M | ﹤0.01% |
1,668,431
-347,562
| -17% | -$6.43M |
2022 Q2
15 quarters
|
|
1961
Stantec
STN
$7.58B
| $26.5M | ﹤0.01% |
307,054
+162,133
| +112% | +$15.2M |
2025 Q4
1 quarter
|
|
1962
PUT
Tenet Healthcare
THC
$20.8B
| $26.5M | ﹤0.01% |
140,400
-25,800
| -16% | -$5.44M |
2013 Q2
51 quarters
|
|
1963
UBS Group
UBS
$146B
| $26.5M | ﹤0.01% |
677,062
+593,439
| +710% | +$25.4M |
2023 Q1
12 quarters
|
|
|
KEEL
1964
Keel Infrastructure Corp
KEEL
$2.24B
| $26.5M | ﹤0.01% |
13,565,213
-6,453,322
| -32% | -$15.2M |
2023 Q2
11 quarters
|
|
1965
Deutsche Bank
DB
$65.7B
| $26.4M | ﹤0.01% |
887,690
+239,126
| +37% | +$8.42M |
2023 Q2
11 quarters
|
|
1966
CALL
iShares Biotechnology ETF
IBB
$10.5B
| $26.4M | ﹤0.01% |
156,400
-3,100
| -2% | -$530K |
2016 Q3
38 quarters
|
|
|
CON
1967
Concentra Group Holdings
CON
$4.55B
| $26.4M | ﹤0.01% |
1,230,675
-1,020,054
| -45% | -$22.7M |
2024 Q3
6 quarters
|
|
|
EXK
1968
Endeavour Silver
EXK
$2.55B
| $26.4M | ﹤0.01% |
2,831,775
+884,226
| +45% | +$9.99M |
2013 Q2
51 quarters
|
|
1969
PUT
KB Home
KBH
$2.78B
| $26.3M | ﹤0.01% |
509,100
-51,600
| -9% | -$3.03M |
2013 Q2
51 quarters
|
|
1970
Celanese
CE
$4.85B
| $26.3M | ﹤0.01% |
399,794
-1,850,173
| -82% | -$96.6M |
2024 Q1
8 quarters
|
|
1971
PTC Therapeutics
PTCT
$5.3B
| $26.2M | ﹤0.01% |
385,199
-769,256
| -67% | -$54.5M |
2023 Q2
11 quarters
|
|
1972
Global X Uranium ETF
URA
$5.57B
| $26.2M | ﹤0.01% |
541,842
+536,326
| +9,723% | +$27.9M |
2020 Q3
22 quarters
|
|
1973
ESCO Technologies
ESE
$7.12B
| $26.2M | ﹤0.01% |
+93,116
| New | +$23.5M |
2026 Q1
0 quarters
|
|
1974
NNN REIT
NNN
$7.86B
| $26.2M | ﹤0.01% |
623,336
+160,697
| +35% | +$6.92M |
2025 Q4
1 quarter
|
|
1975
STAG Industrial
STAG
$6.95B
| $26.2M | ﹤0.01% |
726,478
-605,571
| -45% | -$23M |
2025 Q3
2 quarters
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.